Pulmonx (LUNG) Short Interest Ratio & Short Volume

Short interest is the volume of Pulmonx shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 986,100 shares of LUNG short. Learn More on Pulmonx's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LUNG shares currently have a short interest ratio of 4.0. Learn More on Pulmonx's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pulmonx: Jane Street Group LLC, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Pulmonx saw a drop in short interest in October. As of October 31st, there was short interest totaling 986,100 shares, a drop of 44.6% from the previous total of 1,780,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Pulmonx: Cerus Co. (4.27%), Inovio Pharmaceuticals, Inc. (13.60%), Atrion Co. (3.25%), National Vision Holdings, Inc. (6.72%), Paragon 28, Inc. (17.50%), Liquidia Co. (12.20%), Avanos Medical, Inc. (1.35%), Embecta Corp. (3.30%), Butterfly Network, Inc. (8.81%), Iradimed Corporation (1.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling LUNG is an investing strategy that aims to generate trading profit from Pulmonx as its price is falling. LUNG shares are trading up $0.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Pulmonx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LUNG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LUNG, twice per month. The most recent reporting period available is October, 31 2024.